INS and type 2 diabetes mellitus: Irving et al. compared combined pioglitazone and metformin treatment to placebo in a White European T2DM cohort and found significant reductions in phenylalanine and tyrosine, 3 months following treatment [30], but there was no dose response effect between insulin sensitivity and reductions in amino acids, and no change in the BCAA [33].